History

A list of downloadable documents created during development.

Background information

Renal cell carcinoma (first line metastatic) - pazopanib: Equality Impact Assessment form

Renal cell carcinoma (first line metastatic) - pazopanib: final appraisal determination

Renal cell carcinoma (first line metastatic) - pazopanib: final scope

Renal cell carcinoma (first line metastatic) - pazopanib: Institute's response to consultee and commentator comments on the draft scope

Renal cell carcinoma (first line metastatic) - pazopanib: Institute's response to consultee and commentator comments on the provisional matrix

Renal cell carcinoma (first line metastatic) - pazopanib: provisional matrix

Renal cell carcinoma (first line metastatic) - pazopanib: draft scope